B E Stewart - JoVE Visualize

Showing results (41-50 of 53) with videos related to

Pageof 6

Sort By:

Science Translational Medicine|October 16, 2015

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human seraJoan O Ngwuta, Man Chen, Kayvon Modjarrad, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018

Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.

Science (New York, N.Y.)|November 2, 2013

Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virusJason S McLellan, Man Chen, M Gordon Joyce, et al.

Nature|October 9, 2014

Structure and immune recognition of trimeric pre-fusion HIV-1 EnvMarie Pancera, Tongqing Zhou, Aliaksandr Druz, et al.

Biorxiv : the Preprint Server for Biology|February 3, 2021

mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeMichelle Meyer, Yuan Wang, Darin Edwards, et al.

Cell Reports|December 15, 2024

A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodiesEvan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.

Immunity|March 18, 2018

A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV EnvelopeTongqing Zhou, Anqi Zheng, Ulrich Baxa, et al.

Cell|April 27, 2016

Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.

Journal of Virology|April 26, 2023

Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV NeutralizationMallika Sastry, Anita Changela, Jason Gorman, et al.

Immunity|April 6, 2021

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, Daniel Wrapp, Chen-Hsiang Shen, et al.

Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:

Pageof 6

Science Translational Medicine|October 16, 2015

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human seraJoan O Ngwuta, Man Chen, Kayvon Modjarrad, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018

Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.

Science (New York, N.Y.)|November 2, 2013

Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virusJason S McLellan, Man Chen, M Gordon Joyce, et al.

Nature|October 9, 2014

Structure and immune recognition of trimeric pre-fusion HIV-1 EnvMarie Pancera, Tongqing Zhou, Aliaksandr Druz, et al.

Biorxiv : the Preprint Server for Biology|February 3, 2021

mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeMichelle Meyer, Yuan Wang, Darin Edwards, et al.

Cell Reports|December 15, 2024

A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodiesEvan M Cale, Chen-Hsiang Shen, Adam S Olia, et al.

Immunity|March 18, 2018

A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV EnvelopeTongqing Zhou, Anqi Zheng, Ulrich Baxa, et al.

Cell|April 27, 2016

Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.

Journal of Virology|April 26, 2023

Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV NeutralizationMallika Sastry, Anita Changela, Jason Gorman, et al.

Immunity|April 6, 2021

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, Daniel Wrapp, Chen-Hsiang Shen, et al.

Pageof 6